Skip to content

Johnson & Johnson JNJ Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Procter & Gamble logo
Procter & GamblePG
$347.22B-18.2%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Stryker logo
StrykerSYK
$137.35B-12.4%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.4%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+32.0%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$563.77B+47.3%
P/E26.8×+9.3×
P/S5.9×+1.6×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Calculated from Johnson & Johnson’s reported figures.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's enterprise value?
Johnson & Johnson (JNJ) reported enterprise value of $622.06B in Q1 2026.
How has Johnson & Johnson's enterprise value changed year-over-year?
Johnson & Johnson's enterprise value increased by 50.5% year-over-year, from $413.43B to $622.06B.
What is the long-term trend for Johnson & Johnson's enterprise value?
Over 4 years (2021 to 2025), Johnson & Johnson's enterprise value has grown at a -0.1% compound annual growth rate (CAGR), from $1.82T to $1.81T.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.